2Syrjanen S,Shabalova IP,Petrovichev N,et al.Human papillomavirus testing and conventional Pap smear cytology as optional screening tools of women at different risks for cervical cancer in Countries of the former Soviet Union.J Low Genit Tract Dis,2002,6:97-110.
3Bosch FX,Manos MM,Munoz N,et al.Prevalence of human papillomavirus in cervical cancer:a worldwide perspective.International biological study on cervical cancer (IBSCC) Study Group.J Natl Cancer Inst,1995,87:796-802.
4Vizcaino AP,Moreno V,Bosch FX,et al.International trends in incidence of cervical cancer:Ⅱ.Squamous-cell carcinoma.Int J Cancer,2000,86:429-435.
5Munoz N,Bosch FX,de Sanjose S,et al.Epidemiologic classification of human papillomavirus types associated with cervical cancer.N Engl J Med,2003,348:518-527.
6Clavel C,Masure M,Bory JP,et al.Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions:a study of 7932 women.Br J Cancer,2001,84:1616-1623.
7Blumenthal PD,Gaffikin L,Chirenje ZM,et al.Adjunctive testing for cervical cancer in low resource settings with visual inspection,HPV,and the Pap smear.Int J Gynaecol Obstet,2001,72:47-53.
8Kuhn L,Denny L,Pollack A,et al.Human papillomavirus DNA testing for cervical cancer screening in low-resource settings.J Natl Cancer Inst,2000,92:818-825.
9Saslow D,Runowicz CD,Solomon D,et al.American cancer society guideline for the early detection of cervical neoplasia and cancer.CA Cancer J Clin,2002,52:342-362.
10Sherman ME,Lorincz AT,Scott DR,et al.Baseline cytology,human papillomavirus testing,and risk for cervical neoplasia:a 10-year cohort analysis.J Natl Cancer Inst,2003,95:46-52.
